, Habitual and goal-directed behavioural control in Gilles de la Tourette syndrome

Y. Worbe, A. Salvador, C. Delorme, S. Palminteri, R. E. Voon et al., En cours soumission à Translational Psychiatry

, Autres travaux de recherche Mast cells' involvement in inflammation pathways linked to depression : evidence in mastocytosis

S. Georgin-lavialle, D. S. Moura, A. Salvador, J. C. Chauvet-gelinier, J. M. Launay et al., , 2016.

, Neuroimaging evidence of brain abnormalities in mastocytosis

A. Salvador, N. Boddaert, M. O. Chandesris, H. Lemaître, D. Grévent et al., En révision à Translational Psychiatry

, Unconscious memory suppression

A. Salvador, F. Vinckier, S. Smadja, L. Cohen, L. Naccache et al., En review à Cognition

, Everolimus induced mood changes in breast cancer patients : a case-control study

O. Mir, . Salvador, . Dauchy, . Ropert, C. Delaloge et al., En review à European Journal of Cancer

S. G. Potkin, Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder, Arch Gen Psychiatry, vol.60, pp.681-690, 2003.

T. A. Pigott, Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study, J Clin Psychiatry, vol.64, pp.1048-1056, 2003.

J. M. Kane, Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder, J Clin Psychiatry, vol.63, pp.763-771, 2002.

W. Kawohl and F. Schneider, Vernaleken, I. & Neuner, I. Aripiprazole in the pharmacotherapy of Gilles de la Tourette syndrome in adult patients, The world journal of biological psychiatry, vol.10, pp.827-831, 2009.

I. Neuner, C. Nordt, F. Schneider, and W. Kawohl, Effectiveness of aripiprazole in the treatment of adult Tourette patients up to 56 months, Hum Psychopharmacol, vol.27, pp.364-369, 2012.

L. Citrome, I. Kalsekar, R. A. Baker, and T. Hebden, A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults, Curr Med Res Opin, vol.30, pp.1629-1641, 2014.

T. S. Stroup, A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP), Am J Psychiatry, vol.168, pp.947-956, 2011.

A. Hartmann and Y. Worbe, Pharmacological treatment of Gilles de la Tourette syndrome, Neurosci Biobehav Rev, vol.37, pp.1157-1161, 2013.

M. J. Frank, L. C. Seeberger, and R. C. O'reilly, By carrot or by stick: cognitive reinforcement learning in parkinsonism, Science, vol.306, pp.1940-1943, 2004.

C. Eisenegger, Role of dopamine D2 receptors in human reinforcement learning, Neuropsychopharmacology, vol.39, pp.2366-2375, 2014.

M. Pessiglione, B. Seymour, G. Flandin, R. J. Dolan, and C. D. Frith, Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans, Nature, vol.442, pp.1042-1045, 2006.

Y. Worbe, Reinforcement learning and Gilles de la Tourette syndrome: dissociation of clinical phenotypes and pharmacological treatments, Arch Gen Psychiatry, vol.68, pp.1257-1266, 2011.

J. P. O'doherty, S. W. Lee, and D. Mcnamee, The structure of reinforcement-learning mechanisms in the human brain, Current Opinion in Behavioral Sciences, vol.1, pp.94-100, 2015.

G. Coricelli and A. Rustichini, Counterfactual thinking and emotions: regret and envy learning, Philosophical transactions of the Royal Society of London. Series B, Biological sciences, vol.365, pp.241-247, 2010.

G. Coricelli, R. J. Dolan, and A. Sirigu, Brain, emotion and decision making: the paradigmatic example of regret, Trends in cognitive sciences, vol.11, pp.258-265, 2007.

E. D. Boorman, T. E. Behrens, and M. F. Rushworth, Counterfactual choice and learning in a neural network centered on human lateral frontopolar cortex, PLoS biology, vol.9, p.1001093, 2011.

, American Psychiatric Association, A. Diagnostic and Statistical Manual of Mental Disorders, 2013.

H. J. Conradi, J. Ormel, and P. De-jonge, Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study, Psychol Med, vol.41, pp.1165-1174, 2011.

G. L. Iverson and R. W. Lam, Rapid screening for perceived cognitive impairment in major depressive disorder, Ann Clin Psychiatry, vol.25, pp.135-140, 2013.

R. W. Lam, Which depressive symptoms and medication side effects are perceived by patients as interfering most with occupational functioning?, Depress Res Treat, vol.2012, p.630206, 2012.

P. L. Rock, J. P. Roiser, W. J. Riedel, and A. D. Blackwell, Cognitive impairment in depression: a systematic review and meta-analysis, Psychol Med, vol.44, pp.2029-2040, 2014.

C. Chen, T. Takahashi, S. Nakagawa, T. Inoue, and I. Kusumi, Reinforcement learning in depression: A review of computational research, Neuroscience and biobehavioral reviews, vol.55, pp.247-267, 2015.

R. A. Adams, Q. J. Huys, and J. P. Roiser, Computational Psychiatry: towards a mathematically informed understanding of mental illness, Journal of neurology, vol.87, pp.53-63, 2016.

A. Heinz, F. Schlagenhauf, A. Beck, and C. Wackerhagen, Dimensional psychiatry: motivation: A review and enquiry, Behav Brain Res, vol.290, pp.17-31, 2015.

W. Schultz, Dopamine reward prediction error coding, Dialogues in clinical neuroscience, vol.18, pp.23-32, 2016.

Y. Niv, Cost, benefit, tonic, phasic: what do response rates tell us about dopamine and motivation?, Ann N Y Acad Sci, vol.1104, pp.357-376, 2007.

R. A. Wise and . Dopamine, learning and motivation, Nat Rev Neurosci, vol.5, pp.483-494, 2004.

K. Friston, The anatomy of choice: active inference and agency, Front Hum Neurosci, vol.7, p.598, 2013.

R. B. Rutledge, N. Skandali, P. Dayan, and R. J. Dolan, Dopaminergic Modulation of Decision Making and Subjective Well-Being, J Neurosci, vol.35, pp.9811-9822, 2015.

R. Cools, R. A. Barker, B. J. Sahakian, and T. W. Robbins, L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease, Neuropsychologia, vol.41, pp.1431-1441, 2003.

C. J. Browne and P. J. Fletcher, Decreased Incentive Motivation Following Knockout or Acute Blockade of the Serotonin Transporter: Role of the 5-HT2C Receptor, Neuropsychopharmacology, vol.41, pp.2566-2576, 2016.

F. Chenu, M. El-mansari, and P. Blier, Electrophysiological effects of repeated administration of agomelatine on the dopamine, norepinephrine, and serotonin systems in the rat brain, Neuropsychopharmacology, vol.38, pp.275-284, 2013.

M. J. Millan, The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways, J Pharmacol Exp Ther, vol.306, pp.954-964, 2003.

S. L. Dewey, Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis, The Journal of neuroscience, vol.15, pp.821-829, 1995.

E. Dremencov, M. El-mansari, and P. Blier, Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area, Journal of psychiatry and neuroscience, vol.34, pp.223-229, 2009.

G. Fervaha, G. Foussias, H. Takeuchi, O. Agid, and G. Remington, Motivational deficits in major depressive disorder: Cross-sectional and longitudinal relationships with functional impairment and subjective well-being, Comprehensive psychiatry, vol.66, pp.31-38, 2016.

. Bibliographie,

K. M. Abel, M. P. Allin, D. R. Hemsley, and M. A. Geyer, Low dose ketamine increases prepulse inhibition in healthy men, Neuropharmacology, vol.44, issue.6, pp.729-737, 2003.

L. Abramson and M. Seligman, Modeling psychopathology in the laboratory : History and rationale, Psychopathology : Experimental Models, pp.1-26, 1977.

A. Albacete, F. Contreras, C. Bosque, E. Gilabert, Á. Albiach et al., Counterfactual Reasoning in Non-psychotic FirstDegree Relatives of People with Schizophrenia, Frontiers in Psychology, vol.7, 2016.

R. L. Albin and J. W. Mink, Recent advances in Tourette syndrome research, Trends Neurosci, vol.29, issue.3, pp.175-182, 2006.

A. Aleman and A. Vercammen, The Neuroscience of Hallucinations, 2012.

A. Jardri, P. Cachia, and . Thomas, , pp.107-122

J. Alsiö, S. R. Nilsson, F. Gastambide, R. A. Wang, S. A. Dam et al., The role of 5-HT2C receptors in touchscreen visual reversal learning in the rat : a cross-site study, Psychopharmacology, vol.232, pp.4017-4031, 2015.

A. American-psychiatric-association, Diagnostic and Statistical Manual of Mental Disorders, 2013.

N. L. Anderson, The clinical plasma proteome : a survey of clinical assays for proteins in plasma and serum, Clinical Chemistry, vol.56, issue.2, pp.177-185, 2010.

N. Antypa, R. Calati, and A. Serretti, The neuropsychological hypothesis of antidepressant drug action revisited, CNS Neurol Disord Drug Targets, vol.13, issue.10, pp.1722-1739, 2014.

B. W. Balleine, Neural bases of food-seeking : affect, arousal and reward in corticostriatolimbic circuits, Physiol Behav, vol.86, issue.5, 2005.

M. F. Barbano and M. Cador, Differential regulation of the consummatory, motivational and anticipatory aspects of feeding behavior by dopaminergic and opioidergic drugs, Neuropsychopharmacology, issue.7, pp.1371-1381, 2006.

C. Barbui, A. Cipriani, V. Patel, J. L. Ayuso-mateos, and M. V. Ommeren, Efficacy of antidepressants and benzodiazepines in minor depression : systematic review and meta-analysis, The British Journal of Psychiatry, vol.198, issue.1, pp.11-17, 2011.

C. Barkus, D. J. Sanderson, J. N. Rawlins, M. E. Walton, P. J. Harrison et al., What causes aberrant salience in schizophrenia ? A role for impaired short-term habituation and the GRIA1 (GluA1) AMPA receptor subunit, Molecular Psychiatry, vol.19, issue.10, pp.1060-1070, 2014.

O. Bartra, J. T. Mcguire, and J. W. Kable, The valuation system : a coordinate-based meta-analysis of BOLD fMRI experiments examining neural correlates of subjective value, NeuroImage, vol.76, pp.412-427, 2013.

A. Baskin-sommers, A. M. Stuppy-sullivan, and J. W. Buckholtz, Psychopathic individuals exhibit but do not avoid regret during counterfactual decision making, Proceedings of the National Academy of Sciences of the United States of America, vol.113, pp.14438-14443, 2016.

H. M. Bayer and P. W. Glimcher, Midbrain dopamine neurons encode a quantitative reward prediction error signal, Neuron, vol.47, issue.1, pp.129-141, 2005.

C. G. Begley and L. M. Ellis, Drug development : Raise standards for preclinical cancer research, Nature, vol.483, issue.7391, pp.531-533, 2012.

D. Belin, A. Belin-rauscent, J. E. Murray, and B. J. Everitt, Addiction : failure of control over maladaptive incentive habits, Current Opinion in Neurobiology, vol.23, issue.4, pp.564-572, 2013.

R. F. Bell, Ketamine for chronic non-cancer pain, Pain, vol.141, issue.3, pp.210-214, 2009.

R. Bellman, Dynamic programming, 1957.

C. Belzung, Innovative drugs to treat depression : did animal models fail to be predictive or did clinical trials fail to detect effects ?, Neuropsychopharmacology, vol.39, issue.5, pp.1041-1051, 2014.

C. Belzung and M. Lemoine, Criteria of validity for animal models of psychiatric disorders : focus on anxiety disorders and depression, Biology of Mood and Anxiety Disorders, vol.1, issue.1, 2011.
URL : https://hal.archives-ouvertes.fr/halshs-00792412

C. M. Bennett, A. A. Baird, M. B. Miller, and G. L. Wolford, Neural correlates of interspecies perspective taking in the post-mortem atlantic salmon : an argument for proper multiple comparisons correction, Journal of Serendipitous and Unexpected Results, vol.1, pp.1-5, 2011.

R. P. Bentall, R. Corcoran, R. Howard, N. Blackwood, and P. Kinderman, Persecutory delusions : a review and theoretical integration, Clinical Psychology Review, vol.21, issue.8, pp.1143-1192, 2001.

R. P. Bentall, P. Kinderman, and S. Kaney, The self, attributional processes and abnormal beliefs : towards a model of persecutory delusions, Behaviour Research and Therapy, vol.32, issue.3, pp.331-341, 1994.

F. Berna, C. Huron, M. Kazes, I. Offerlin-meyer, D. Willard et al.,

J. Danion, Chronic persecutory delusion and autobiographical memories in patients with schizophrenia : a diary study, The Israel Journal of Psychiatry and Related Sciences, vol.51, issue.1, pp.25-33, 2014.

G. S. Berns, S. M. Mcclure, G. Pagnoni, and P. R. Montague, Predictability modulates human brain response to reward, The Journal of Neuroscience, vol.21, issue.8, pp.2793-2798, 2001.

K. C. Berridge and T. E. Robinson, Parsing reward, Trends in Neurosciences, vol.26, issue.9, pp.233-242, 2003.

N. Besnier, F. Richard, X. Zendjidjian, A. Kaladjian, P. Mazzola-pomietto et al., Stroop and emotional Stroop interference in unaffected relatives of patients with schizophrenic and bipolar disorders : distinct markers of vulnerability ?, The World Journal of Biological Psychiatry, vol.10, issue.4, pp.809-818, 2009.

A. Bespalov, R. Müller, A. Relo, and T. Hudzik, Drug Tolerance : A Known Unknown in Translational Neuroscience, Trends in Pharmacological Sciences, vol.37, issue.5, pp.364-378, 2016.

A. Bespalov, T. Steckler, B. Altevogt, E. Koustova, P. Skolnick et al.,

M. Macleod, Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets, Nature Reviews. Drug Discovery, vol.15, issue.7, 2016.

M. H. Bloch and J. F. Leckman, Clinical course of Tourette syndrome, Journal of Psychosomatic Research, vol.67, issue.6, pp.497-501, 2009.

M. I. Blonk, B. G. Koder, P. M. Bemt, . Van-den, and F. J. Huygen, Use of oral ketamine in chronic pain management : a review, European Journal of Pain, vol.14, issue.5, pp.466-472, 2010.

R. Bogdan, Y. S. Nikolova, and D. A. Pizzagalli, Neurogenetics of depression : a focus on reward processing and stress sensitivity, Neurobiology of Disease, vol.52, pp.12-23, 2013.

I. Bolstad, O. A. Andreassen, I. R. Groote, B. Haatveit, A. Server et al., No difference in frontal cortical activity during an executive functioning task after acute doses of aripiprazole and haloperidol, Frontiers in Human Neuroscience, vol.9, 2015.

E. D. Boorman, T. E. Behrens, and M. F. Rushworth, Counterfactual choice and learning in a neural network centered on human lateral frontopolar cortex, PLoS Biology, vol.9, issue.6, 2011.

E. Bora and C. Pantelis, Theory of mind impairments in first-episode psychosis, individuals at ultra-high risk for psychosis and in first-degree relatives of schizophrenia : systematic review and meta-analysis, Schizophrenia Research, vol.144, issue.1-3, pp.31-36, 2013.

D. Borsboom and A. O. Cramer, Network analysis : an integrative approach to the structure of psychopathology, Annual Review of Clinical Psychology, vol.9, pp.91-121, 2013.

F. Borsini, K. Evans, K. Jason, F. Rohde, B. Alexander et al., Pharmacology of flibanserin, CNS Drug Reviews, vol.8, issue.2, pp.117-142, 2002.

. Bour, RetD : Servier se recentre sur 5 axes majeurs pour innover, 2016.

N. J. Brandon, J. K. Millar, C. Korth, H. Sive, K. K. Singh et al., Understanding the role of DISC1 in psychiatric disease and during normal development, The Journal of Neuroscience, vol.29, issue.41, pp.12768-12775, 2009.

S. Brenner, Nobel lecture : nature's gift to science, Bioscience Reports, vol.23, issue.5, pp.225-237, 2003.

M. R. Broome, L. C. Johns, I. Valli, J. B. Woolley, P. Tabraham et al.,

P. K. Mcguire, Delusion formation and reasoning biases in those at clinical high risk for psychosis, The British Journal of Psychiatry, vol.51, pp.38-42, 2007.

P. F. Buckley, B. J. Miller, D. S. Lehrer, and D. J. Castle, Psychiatric comorbidities and schizophrenia, Schizophrenia Bulletin, vol.35, issue.2, pp.383-402, 2009.

M. Buoli and A. Caldiroli, IQ as a Cognitive Marker of Genetic Liability in Relatives of Schizophrenia Patients, The American Journal of Psychiatry, vol.172, issue.8, pp.793-794, 2015.

J. D. Buxbaum, DSM-5 and psychiatric genetics -round hole, meet square peg, Biological Psychiatry, vol.77, issue.9, pp.766-768, 2015.

J. F. Cade, Lithium salts in the treatment of psychotic excitement, The Medical Journal of Australia, vol.2, issue.10, pp.349-352, 1949.

N. Camille, G. Coricelli, J. Sallet, P. Pradat-diehl, J. Duhamel et al., The involvement of the orbitofrontal cortex in the experience of regret, Science, vol.304, issue.5674, pp.1167-1170, 2004.
URL : https://hal.archives-ouvertes.fr/hal-00272127

R. L. Carhart-harris, S. Brugger, D. J. Nutt, and J. M. Stone, Psychiatry's next top model : cause for a re-think on drug models of psychosis and other psychiatric disorders, Journal of Psychopharmacology, vol.27, issue.9, pp.771-778, 2013.

S. T. Carmichael and J. L. Price, Architectonic subdivision of the orbital and medial prefrontal cortex in the macaque monkey, The Journal of Comparative Neurology, vol.346, issue.3, pp.366-402, 1994.

M. Carstensen and A. M. Møller, Adding ketamine to morphine for intravenous patient-controlled analgesia for acute postoperative pain : a qualitative review of randomized trials, British Journal of Anaesthesia, vol.104, issue.4, pp.401-406, 2010.

B. Cassetta and V. Goghari, Theory of mind reasoning in schizophrenia patients and non-psychotic relatives, Psychiatry Research, vol.218, issue.1-2, pp.12-19, 2014.

I. Chalmers and P. Glasziou, Avoidable waste in the production and reporting of research evidence, Lancet, vol.374, issue.9683, pp.60329-60338, 2009.

S. R. Chamberlain, U. Müller, A. D. Blackwell, L. Clark, T. W. Robbins et al., Neurochemical modulation of response inhibition and probabilistic learning in humans, Science, issue.5762, pp.861-863, 2006.

L. J. Chapman, J. P. Chapman, and M. L. Raulin, Scales for physical and social anhedonia, Journal of Abnormal Psychology, vol.85, issue.4, pp.374-382, 1976.

P. Chaste, L. Klei, S. J. Sanders, V. Hus, M. T. Murtha et al., A genome-wide association study of autism using the Simons Simplex Collection : Does reducing phenotypic heterogeneity in autism increase genetic homogeneity ?, Biological Psychiatry, vol.77, issue.9, pp.775-784, 2015.

C. Chen, T. Takahashi, S. Nakagawa, T. Inoue, and I. Kusumi, Reinforcement learning in depression : A review of computational research, Neuroscience and Biobehavioral Reviews, vol.55, pp.247-267, 2015.

G. Chen, F. Wang, B. C. Dillenburger, R. M. Friedman, L. M. Chen et al., Functional magnetic resonance imaging of awake monkeys : some approaches for improving imaging quality, Magnetic Resonance Imaging, vol.30, issue.1, pp.36-47, 2012.

E. Childs and H. D. Wit, Amphetamine-induced place preference in humans, Biological Psychiatry, vol.65, issue.10, pp.900-904, 2009.

E. Chkonia, M. Roinishvili, M. H. Herzog, and A. Brand, First-order relatives of schizophrenic patients are not impaired in the Continuous Performance Test, Journal of Clinical and Experimental Neuropsychology, vol.32, issue.5, pp.481-486, 2010.

A. Cipriani, T. A. Furukawa, G. Salanti, J. R. Geddes, J. P. Higgins et al., Comparative efficacy and acceptability of 12 new-generation antidepressants : a multiple-treatments meta-analysis, Lancet, vol.373, issue.9665, pp.60046-60051, 2009.

J. Cohen, A coefficient of agreement for nominal scales, Educational and Psychological Measurement, vol.20, issue.1, pp.37-46, 1960.

A. G. Collins and M. J. Frank, How much of reinforcement learning is working memory, not reinforcement learning ? A behavioral, computational, and neurogenetic analysis, Eur J Neurosci, vol.35, issue.7, pp.1024-1035, 2012.

M. Coltheart, Cognitive neuropsychiatry and delusional belief, Quarterly Journal of Experimental Psychology, vol.60, issue.8, pp.1041-1062, 2007.

M. Coltheart, R. Langdon, and R. Mckay, Delusional belief, Annual Review of Psychology, vol.62, pp.271-298, 2011.

M. H. Connors and P. W. Halligan, A cognitive account of belief : a tentative road map, Frontiers in Psychology, vol.5, p.1588, 2015.

I. S. Consortium, S. M. Purcell, N. R. Wray, J. L. Stone, P. M. Visscher et al., Common polygenic variation contributes to risk of schizophrenia and bipolar disorder, Nature, vol.460, issue.7256, pp.748-752, 2009.

D. Cook, D. Brown, R. Alexander, R. March, P. Morgan et al., Lessons learned from the fate of AstraZeneca's drug pipeline : a five-dimensional framework, Nat Rev Drug Discov, vol.13, issue.6, pp.419-431, 2014.

R. Cools and M. Esposito, Inverted-U-shaped dopamine actions on human working memory and cognitive control, Biological Psychiatry, vol.69, issue.12, pp.113-125, 2011.

R. Cools, M. J. Frank, S. E. Gibbs, A. Miyakawa, W. Jagust et al., Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration, The Journal of Neuroscience, vol.29, issue.5, pp.1538-1543, 2009.

R. Cools, O. J. Robinson, and B. Sahakian, Acute tryptophan depletion in healthy volunteers enhances punishment prediction but does not affect reward prediction, Neuropsychopharmacology, vol.33, issue.9, pp.2291-2299, 2008.

J. A. Cooper, V. L. Tucker, and G. I. Papakostas, Resolution of sleepiness and fatigue : a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union, Journal of Psychopharmacology, vol.28, issue.2, pp.118-124, 2014.

D. Corbett and R. A. Wise, Intracranial self-stimulation in relation to the ascending dopaminergic systems of the midbrain : a moveable electrode mapping study, Brain Research, vol.185, issue.1, pp.1-15, 1980.

G. Coricelli and A. Rustichini, Counterfactual thinking and emotions : regret and envy learning, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, vol.365, pp.241-247, 1538.

G. Coricelli, H. D. Critchley, M. Joffily, J. P. O'doherty, A. Sirigu et al., Regret and its avoidance : a neuroimaging study of choice behavior, Nature Neuroscience, vol.8, issue.9, pp.1255-1262, 2005.

P. R. Corlett, G. D. Honey, and P. C. Fletcher, From prediction error to psychosis : ketamine as a pharmacological model of delusions, J Psychopharmacol, vol.21, issue.3, pp.238-252, 2007.

P. R. Corlett, G. D. Honey, M. R. Aitken, A. Dickinson, D. R. Shanks et al.,

P. C. Fletcher, Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine : linking cognition, brain activity, and psychosis, Arch Gen Psychiatry, vol.63, issue.6, pp.611-621, 2006.

P. R. Corlett, J. R. Taylor, X. Wang, P. C. Fletcher, and J. H. Krystal, , 2010.

, Prog Neurobiol, vol.92, issue.3, pp.345-369

C. U. Correll, T. Kishimoto, and J. M. Kane, Randomized controlled trials in schizophrenia : opportunities, limitations, and trial design alternatives, Dialogues in Clinical Neuroscience, vol.13, issue.2, pp.155-172, 2011.

B. Costall, R. J. Naylor, and V. Nohria, Hyperactivity response to apomorphine and amphetamine in the mouse : the importance of the nucleus accumbens and caudate-putamen, The Journal of Pharmacy and Pharmacology, vol.31, issue.4, pp.259-261, 1979.

I. Creese, D. R. Burt, and S. H. Snyder, Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs, Science, vol.192, issue.4238, pp.481-483, 1976.

H. C. Cromwell and W. Schultz, Effects of expectations for different reward magnitudes on neuronal activity in primate striatum, Journal of Neurophysiology, vol.89, issue.5, pp.2823-2838, 2003.

J. F. Cryan, A. Markou, and I. Lucki, Assessing antidepressant activity in rodents : recent developments and future needs, Trends in Pharmacological Sciences, vol.23, issue.5, pp.238-245, 2002.

J. F. Cryan, C. Sánchez, T. G. Dinan, and F. Borsini, Psychiatric Disorders, vol.1, pp.165-198, 2008.

H. V. Curran, D. C. Souza, T. W. Robbins, and P. Fletcher, Modelling psychosis, Psychopharmacology, vol.206, issue.4, pp.513-514, 2009.

F. Cushman and A. Morris, Habitual control of goal selection in humans, Proceedings of the National Academy of Sciences of the United States of America, vol.112, pp.13817-13822, 2015.

B. Cuthbert and T. Insel, The data of diagnosis : new approaches to psychiatric classification, Psychiatry, vol.73, issue.4, pp.311-314, 2010.

N. D. Daw, Decision making, affect, and learning : Attention and performance XXIII, Decision making, affect, and learning : Attention and performance XXIII, vol.23, pp.3-38, 2011.

N. D. Daw, S. Kakade, and P. Dayan, Opponent interactions between serotonin and dopamine, Neural Networks, vol.15, issue.4-6, pp.603-616, 2002.

N. D. Daw, Y. Niv, and P. Dayan, Uncertainty-based competition between prefrontal and dorsolateral striatal systems for behavioral control, Nat Neurosci, vol.8, issue.12, pp.1704-1711, 2005.

P. Dayan, Twenty-five lessons from computational neuromodulation, Neuron, vol.76, issue.1, pp.240-256, 2012.

P. Dayan and L. F. Abbott, Theoretical Neuroscience : Computational and Mathematical Modeling of Neural Systems (Computational Neuroscience Series, 2005.

J. F. Deakin, J. Lees, S. Mckie, J. E. Hallak, S. R. Williams et al., Glutamate and the neural basis of the subjective effects of ketamine : a pharmaco-magnetic resonance imaging study, Arch Gen Psychiatry, vol.65, issue.2, pp.154-164, 2008.

J. Delay and J. F. Buisson, Psychic action of isoniazid in the treatment of depressive states, Journal of Clinical and Experimental Psychopathology, vol.19, issue.2, pp.51-55, 1958.

A. Der-avakian, S. A. Barnes, A. Markou, and D. A. Pizzagalli, Translational Assessment of Reward and Motivational Deficits in Psychiatric Disorders, Current Topics in Behavioral Neurosciences, vol.28, pp.231-262, 2016.

A. Der-avakian, M. S. Souza, D. A. Pizzagalli, and A. Markou, Assessment of reward responsiveness in the response bias probabilistic reward task in rats : implications for cross-species translational research, Translational Psychiatry, vol.3, 2013.

M. J. Detke, M. Rickels, and I. Lucki, Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants, Psychopharmacology, vol.121, issue.1, pp.66-72, 1995.

L. Di, H. Rong, and B. Feng, Demystifying brain penetration in central nervous system drug discovery. Miniperspective, Journal of Medicinal Chemistry, vol.56, issue.1, pp.2-12, 2013.

G. S. Dichter, M. J. Smoski, A. B. Kampov-polevoy, R. Gallop, and J. C. Garbutt, Unipolar depression does not moderate responses to the Sweet Taste Test, Depression and Anxiety, vol.27, issue.9, pp.859-863, 2010.
DOI : 10.1002/da.20690

URL : http://europepmc.org/articles/pmc2935496?pdf=render

A. Dickinson, Actions and habits : the development of behavioural autonomy, Philosophical Transactions of the Royal Society of London B : Biological Sciences, vol.308, pp.67-78, 1135.

Y. Ding, F. Pereira, A. Hoehne, M. Beaulieu, M. Lepage et al., Altered brain processing of decision-making in healthy firstdegree biological relatives of suicide completers, 2016.

R. J. Dolan and P. Dayan, Goals and habits in the brain, Neuron, vol.80, issue.2, pp.312-325, 2013.

B. B. Doll, K. D. Duncan, D. A. Simon, D. Shohamy, and N. D. Daw, , 2015.

, Model-based choices involve prospective neural activity, Nature Neuroscience, vol.18, issue.5, pp.767-772

S. Dollfus, M. Alary, and A. Razafimandimby, The Neuroscience of Hallucinations, pp.123-136, 2012.

E. F. Domino, E. K. Zsigmond, L. E. Domino, K. E. Domino, S. P. Kothary et al., Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmentographic assay, Anesth Analg, issue.2, pp.87-92, 1982.

C. Dournes, S. Beeské, C. Belzung, and G. Griebel, Deep brain stimulation in treatment-resistant depression in mice : comparison with the CRF1 antagonist, SSR125543, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.40, pp.213-220, 2013.

W. C. Drevets, J. L. Price, J. R. Simpson, R. D. Todd, T. Reich et al., Subgenual prefrontal cortex abnormalities in mood disorders, Nature, vol.386, issue.6627, pp.824-827, 1997.
DOI : 10.1038/386824a0

C. Ducottet, G. Griebel, and C. Belzung, Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.27, issue.4, pp.625-631, 2003.

K. D'ardenne, S. M. Mcclure, L. E. Nystrom, and J. D. Cohen, BOLD responses reflecting dopaminergic signals in the human ventral tegmental area, Science, issue.5867, pp.1264-1267, 2008.

D. C. D'souza, N. Singh, J. Elander, M. Carbuto, B. Pittman et al.,

J. Schipper, Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males : preliminary evidence, Neuropsychopharmacology, vol.37, issue.4, pp.1036-1046, 2012.

S. J. Ebisch and A. Aleman, The fragmented self : imbalance between intrinsic and extrinsic self-networks in psychotic disorders, The Lancet Psychiatry, vol.3, issue.8, pp.45-51, 2016.

B. J. Everitt and T. W. Robbins, Neural systems of reinforcement for drug addiction : from actions to habits to compulsion, Nature Neuroscience, vol.8, issue.11, pp.1481-1489, 2005.

A. Fagiolini, P. Rocca, S. De-giorgi, E. Spina, G. Amodeo et al., Clinical trial methodology to assess the efficacy/effectiveness of long-acting antipsychotics : Randomized controlled trials vs naturalistic studies, Psychiatry Research, vol.247, pp.257-264, 2016.

C. Faravelli, G. Castellini, L. Benni, A. Brugnera, M. Landi et al.,

V. Ricca, Generalized anxiety disorder : is there any specific symptom ?, Comprehensive Psychiatry, vol.53, issue.8, pp.1056-1062, 2012.

M. S. Farrell, T. Werge, P. Sklar, M. J. Owen, R. A. Ophoff et al.,

P. F. Sullivan, Evaluating historical candidate genes for schizophrenia, Molecular Psychiatry, vol.20, issue.5, pp.555-562, 2015.

J. Fawcett, D. C. Clark, W. A. Scheftner, and R. D. Gibbons, Assessing anhedonia in psychiatric patients, Archives of General Psychiatry, vol.40, issue.1, pp.79-84, 1983.

A. B. Fernando and T. W. Robbins, Animal models of neuropsychiatric disorders, Annual Review of Clinical Psychology, vol.7, pp.39-61, 2011.

G. Fervaha, G. Foussias, H. Takeuchi, O. Agid, and G. Remington, Motivational deficits in major depressive disorder : Cross-sectional and longitudinal relationships with functional impairment and subjective well-being, Comprehensive Psychiatry, vol.66, pp.31-38, 2016.

C. D. Fiorillo, P. N. Tobler, and W. Schultz, Discrete coding of reward probability and uncertainty by dopamine neurons, Science, vol.299, issue.5614, pp.1898-1902, 2003.

A. G. Fischer and M. Ullsperger, Real and fictive outcomes are processed differently but converge on a common adaptive mechanism, Neuron, vol.79, issue.6, pp.1243-1255, 2013.

P. C. Fletcher and C. D. Frith, Perceiving is believing : a Bayesian approach to explaining the positive symptoms of schizophrenia, Nat Rev Neurosci, vol.10, issue.1, pp.48-58, 2009.

N. F. Forbes, C. A. Stewart, K. Matthews, and I. C. Reid, Chronic mild stress and sucrose consumption : validity as a model of depression, Physiology and Behavior, vol.60, issue.6, pp.1481-1484, 1996.

J. C. Fournier, R. J. Derubeis, S. D. Hollon, S. Dimidjian, J. D. Amsterdam et al., Antidepressant drug effects and depression severity : a patient-level meta-analysis, JAMA, vol.303, issue.1, pp.47-53, 2010.

M. J. Frank, J. Samanta, A. A. Moustafa, and S. J. Sherman, Hold your horses : impulsivity, deep brain stimulation, and medication in parkinsonism, Science, vol.318, issue.5854, pp.1309-1312, 2007.

M. J. Frank, L. C. Seeberger, and R. C. Reilly, By carrot or by stick : cognitive reinforcement learning in parkinsonism, Science, vol.306, issue.5703, pp.1940-1943, 2004.

R. Freedman, The choice of antipsychotic drugs for schizophrenia, The New England Journal of Medicine, vol.353, issue.12, pp.1286-1288, 2005.

R. Freedman, D. A. Lewis, R. Michels, D. S. Pine, S. K. Schultz et al., The initial field trials of DSM-5 : new blooms and old thorns, vol.170, pp.1-5, 2013.

C. D. Frith, The Cognitive Neuropsychology of Schizophrenia (Essays in Cognitive Psychology), 1992.

M. L. Furey and W. C. Drevets, Antidepressant efficacy of the antimuscarinic drug scopolamine : a randomized, placebo-controlled clinical trial, Archives of General Psychiatry, vol.63, issue.10, pp.1121-1129, 2006.

P. Fusar-poli, I. Bonoldi, A. R. Yung, S. Borgwardt, M. J. Kempton et al., Predicting psychosis : meta-analysis of transition outcomes in individuals at high clinical risk, Archives of General Psychiatry, vol.69, issue.3, pp.220-229, 2012.

D. E. Gard, M. G. Gard, A. M. Kring, and O. P. John, Anticipatory and consummatory components of the experience of pleasure : a scale development study, Journal of Research in Personality, vol.40, issue.6, pp.1086-1102, 2006.

E. L. Gardner and C. R. Ashby, Heterogeneity of the mesotelencephalic dopamine fibers : physiology and pharmacology, Neuroscience and Biobehavioral Reviews, vol.24, issue.1, pp.115-118, 2000.

P. A. Garety and D. Freeman, Cognitive approaches to delusions : a critical review of theories and evidence, Br J Clin Psychol, vol.38, pp.113-154, 1999.

P. A. Garety and D. Freeman, The past and future of delusions research : from the inexplicable to the treatable, The British Journal of Psychiatry, vol.203, issue.5, pp.327-333, 2013.

J. Garrison, B. Erdeniz, and J. Done, Prediction error in reinforcement learning : a meta-analysis of neuroimaging studies, Neuroscience and Biobehavioral Reviews, vol.37, issue.7, pp.1297-1310, 2013.

J. T. Gass and L. J. Chandler, The Plasticity of Extinction : Contribution of the Prefrontal Cortex in Treating Addiction through Inhibitory Learning, Frontiers in Psychiatry, vol.4, 2013.

P. A. Geoffroy, A. Amad, and R. Gaillard, Sciences et psychiatrie. Annales Médico-Psychologiques, vol.172, pp.752-755, 2014.
DOI : 10.1016/j.amp.2014.08.019

E. S. Gershon, N. Alliey-rodriguez, and C. Liu, After GWAS : searching for genetic risk for schizophrenia and bipolar disorder, The American Journal of Psychiatry, vol.168, issue.3, pp.253-256, 2011.
DOI : 10.1176/appi.ajp.2010.10091340

M. A. Geyer and B. Ellenbroek, Animal behavior models of the mechanisms underlying antipsychotic atypicality, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.27, issue.7, pp.1071-1079, 2003.

M. A. Geyer and A. Markou, Psychopharmacology : The Fourth Generation of Progress, 1995.

I. Giegling, L. Hosak, R. Mössner, A. Serretti, F. Bellivier et al., Genetics of schizophrenia : A consensus paper of the WFSBP Task Force on Genetics, The World Journal of Biological Psychiatry, pp.1-14, 2017.

D. L. Gilbert, B. T. Christian, M. J. Gelfand, B. Shi, J. Mantil et al., Altered mesolimbocortical and thalamic dopamine in Tourette syndrome, Neurology, vol.67, issue.9, pp.1695-1697, 2006.
DOI : 10.1212/01.wnl.0000242733.18534.2c

C. M. Gillan, M. Papmeyer, S. Morein-zamir, B. J. Sahakian, N. A. Fineberg et al., Disruption in the balance between goal-directed behavior and habit learning in obsessive-compulsive disorder, The American Journal of Psychiatry, vol.168, issue.7, pp.718-726, 2011.

D. C. Glahn, E. E. Knowles, D. R. Mckay, E. Sprooten, H. Raventós et al., Arguments for the sake of endophenotypes : examining common misconceptions about the use of endophenotypes in psychiatric genetics, American Journal of Medical Genetics, vol.165, issue.2, pp.122-130, 2014.

D. Goldberg, The heterogeneity of "major depression, World Psychiatry, vol.10, issue.3, pp.226-228, 2011.

D. C. Gooding and M. J. Pflum, The assessment of interpersonal pleasure : introduction of the Anticipatory and Consummatory Interpersonal Pleasure Scale (ACIPS) and preliminary findings, Psychiatry Research, vol.215, issue.1, pp.237-243, 2014.

I. H. Gotlib, J. P. Hamilton, R. E. Cooney, M. K. Singh, M. L. Henry et al., Neural processing of reward and loss in girls at risk for major depression, Arch Gen Psychiatry, vol.67, issue.4, pp.380-387, 2010.

I. I. Gottesman and T. D. Gould, The endophenotype concept in psychiatry : etymology and strategic intentions, The American Journal of Psychiatry, vol.160, issue.4, pp.636-645, 2003.
DOI : 10.1176/appi.ajp.160.4.636

I. I. Gottesman and J. Shields, Genetic theorizing and schizophrenia, The British Journal of Psychiatry, vol.122, issue.566, pp.15-30, 1973.
DOI : 10.1192/bjp.122.1.15

I. I. Gottesman, T. M. Laursen, A. Bertelsen, and P. B. Mortensen, Severe mental disorders in offspring with 2 psychiatrically ill parents, Archives of General Psychiatry, vol.67, issue.3, pp.252-257, 2010.

J. A. Gottfried and R. J. Dolan, Human orbitofrontal cortex mediates extinction learning while accessing conditioned representations of value, Nature Neuroscience, vol.7, issue.10, pp.1144-1152, 2004.
DOI : 10.1038/nn1314

URL : http://pubman.mpdl.mpg.de/pubman/item/escidoc:2614729/component/escidoc:2622715/RD_Human_2004.pdf

V. B. Graaf-peters, . De, and M. Hadders-algra, Ontogeny of the human central nervous system : what is happening when ? Early Human Development, vol.82, pp.257-266, 2006.

A. M. Graybiel and J. J. Canales, The neurobiology of repetitive behaviors : clues to the neurobiology of Tourette syndrome, Adv Neurol, vol.85, pp.123-131, 2001.

T. A. Greenwood, D. L. Braff, G. A. Light, K. S. Cadenhead, M. E. Calkins et al., Initial heritability analyses of endophenotypic measures for schizophrenia : the consortium on the genetics of schizophrenia, Archives of General Psychiatry, vol.64, issue.11, pp.1242-1250, 2007.

T. A. Greenwood, L. C. Lazzeroni, M. E. Calkins, R. Freedman, M. F. Green et al., Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study, Schizophrenia Research, vol.170, issue.1, pp.30-40, 2016.

T. A. Greenwood, G. A. Light, N. R. Swerdlow, M. E. Calkins, M. F. Green et al., Gating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family History, The American Journal of Psychiatry, vol.173, issue.4, pp.385-391, 2016.

G. Griebel and S. Beeské, Is there still a future for neurokinin 3 receptor antagonists as potential drugs for the treatment of psychiatric diseases ? Pharmacology and Therapeutics, vol.133, pp.116-123, 2012.

G. Griebel and F. Holsboer, Neuropeptide receptor ligands as drugs for psychiatric diseases : the end of the beginning ?, Nature Reviews. Drug Discovery, vol.11, issue.6, pp.462-478, 2012.

B. D. Group, Biomarkers and surrogate endpoints : preferred definitions and conceptual framework, Clinical Pharmacology and Therapeutics, vol.69, issue.3, pp.89-95, 2001.

X. Gu, X. Wu, Y. Liu, S. Cui, and Z. Ma, Tyrosine phosphorylation of the N-Methyl-D-Aspartate receptor 2B subunit in spinal cord contributes to remifentanil-induced postoperative hyperalgesia : the preventive effect of ketamine, Molecular Pain, vol.5, p.76, 2009.

M. Guitart-masip, E. Duzel, R. Dolan, and P. Dayan, Action versus valence in decision making, Trends in Cognitive Sciences, vol.18, issue.4, pp.194-202, 2014.

D. G. Hackam, Translating animal research into clinical benefit, British Medical Journal, vol.334, issue.7586, pp.163-164, 2007.

D. G. Hackam and D. A. Redelmeier, Translation of research evidence from animals to humans, JAMA, vol.296, issue.14, pp.1731-1732, 2006.

J. E. Hallak, A. L. Paula, . De, C. Chaves, R. A. Bressan et al., An Overview on the Search for Schizophrenia Biomarkers, CNS and Neurological Disorders Drug Targets, vol.14, issue.8, pp.996-1000, 2015.

P. W. Halligan and A. S. David, Cognitive neuropsychiatry : towards a scientific psychopathology, Nature Reviews. Neuroscience, vol.2, issue.3, pp.209-215, 2001.

R. Handley, F. O. Zelaya, A. A. Reinders, T. R. Marques, M. A. Mehta et al., Acute effects of single-dose aripiprazole and haloperidol on resting cerebral blood flow (rCBF) in the human brain, Hum Brain Mapp, vol.34, issue.2, pp.272-282, 2013.

R. B. Harris, J. Zhou, B. D. Youngblood, G. N. Smagin, and D. H. Ryan, Failure to change exploration or saccharin preference in rats exposed to chronic mild stress, Physiology and Behavior, vol.63, issue.1, pp.91-100, 1997.

M. Haruno and M. Kawato, Different neural correlates of reward expectation and reward expectation error in the putamen and caudate nucleus during stimulusaction-reward association learning, Journal of Neurophysiology, vol.95, issue.2, pp.948-959, 2006.

G. Hasler, Can the neuroeconomics revolution revolutionize psychiatry ?, Neuroscience and Biobehavioral Reviews, vol.36, issue.1, pp.64-78, 2012.

M. Hay, D. W. Thomas, J. L. Craighead, C. Economides, and J. Rosenthal, Clinical development success rates for investigational drugs, Nature Biotechnology, vol.32, issue.1, pp.40-51, 2014.

R. Hehlmann, A. Hochhaus, M. Baccarani, and E. Leukemianet, Chronic myeloid leukaemia, Lancet, vol.370, issue.9584, pp.61165-61174, 2007.

D. R. Hemsley, A simple (or simplistic ?) cognitive model for schizophrenia, Behaviour Research and Therapy, vol.31, issue.7, pp.633-645, 1993.

U. Heresco-levy, G. Gelfin, B. Bloch, R. Levin, S. Edelman et al., A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression, The International Journal of Neuropsychopharmacology, vol.16, issue.3, pp.501-506, 2013.

W. D. Hirst, B. Abrahamsen, F. E. Blaney, A. R. Calver, L. Aloj et al., Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling, Molecular Pharmacology, vol.64, issue.6, pp.1295-1308, 2003.

P. H. Hoch, J. P. Catell, and H. H. Pennes, Effects of mescaline and lysergic acid (d-LSD-25), The American Journal of Psychiatry, vol.108, issue.8, pp.579-584, 1952.

J. R. Hollerman and W. Schultz, Dopamine neurons report an error in the temporal prediction of reward during learning, Nature Neuroscience, vol.1, issue.4, pp.304-309, 1998.

P. E. Holtzheimer and H. S. Mayberg, Deep brain stimulation for psychiatric disorders, Annual Review of Neuroscience, vol.34, pp.289-307, 2011.

A. E. Horner, C. J. Heath, M. Hvoslef-eide, B. A. Kent, C. H. Kim et al., The touchscreen operant platform for testing learning and memory in rats and mice, Nature Protocols, vol.8, issue.10, pp.1961-1984, 2013.

C. Hou, Y. Xiang, Z. Wang, I. Everall, Y. Tang et al., Cognitive functioning in individuals at ultra-high risk for psychosis, first-degree relatives of patients with psychosis and patients with first-episode schizophrenia, Schizophrenia Research, vol.174, issue.1-3, pp.71-76, 2016.

R. A. Howard, Dynamic programming and markov processes, 1960.

O. D. Howes and S. Kapur, The dopamine hypothesis of schizophrenia : version III-the final common pathway, Schizophr Bull, vol.35, issue.3, pp.549-562, 2009.

O. Howes, R. Mccutcheon, and J. Stone, Glutamate and dopamine in schizophrenia : an update for the 21st century, Journal of Psychopharmacology, vol.29, issue.2, pp.97-115, 2015.

S. A. Huettel, Event-related fMRI in cognition, NeuroImage, vol.62, issue.2, pp.1152-1156, 2012.

Q. J. Huys, M. Moutoussis, and J. Williams, Are computational models of any use to psychiatry ?, Neural Netw, vol.24, issue.6, pp.544-551, 2011.

T. R. Insel and S. C. Landis, Twenty-five years of progress : the view from NIMH and NINDS, Neuron, vol.80, issue.3, pp.561-567, 2013.

T. R. Insel and E. M. Scolnick, Cure therapeutics and strategic prevention : raising the bar for mental health research, Molecular Psychiatry, vol.11, issue.1, pp.11-17, 2006.

T. R. Insel, V. Voon, J. S. Nye, V. J. Brown, B. M. Altevogt et al., Innovative solutions to novel drug development in mental health, Neuroscience and Biobehavioral Reviews, vol.37, issue.10, pp.2438-2444, 2013.

T. Insel, B. Cuthbert, M. Garvey, R. Heinssen, D. S. Pine et al.,

P. Wang, Research domain criteria (RDoC) : toward a new classification framework for research on mental disorders, Am J Psychiatry, vol.167, issue.7, pp.748-751, 2010.

J. P. Ioannidis, Effectiveness of antidepressants : an evidence myth constructed from a thousand randomized trials ? Philosophy, Ethics, and Humanities in Medicine, vol.3, 2008.

D. C. Javitt, S. R. Zukin, U. Heresco-levy, and D. Umbricht, Has an angel shown the way ? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia, Schizophr Bull, vol.38, issue.5, pp.958-966, 2012.

B. D. Johnson, Psychosis and ketamine, British Medical Journal, vol.4, issue.5784, pp.428-429, 1971.

D. N. Jones, J. E. Gartlon, A. Minassian, W. Perry, and M. A. Geyer, , 2008.

, Psychiatric Disorders, vol.1, pp.199-262

E. M. Jutkiewicz, S. K. Wood, H. Houshyar, L. Hsin, K. C. Rice et al., The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats, Psychopharmacology, vol.180, issue.2, pp.215-223, 2005.

T. Kahnt, J. Heinzle, S. Q. Park, and J. Haynes, The neural code of reward anticipation in human orbitofrontal cortex, Proc Natl Acad Sci U S A, vol.107, issue.13, pp.6010-6015, 2010.

T. Kahnt, S. Q. Park, M. X. Cohen, A. Beck, A. Heinz et al., , 2009.

, Dorsal striatal-midbrain connectivity in humans predicts how reinforcements are used to guide decisions, J Cogn Neurosci, vol.21, issue.7, pp.1332-1345

O. J. Kalant, Moreau, hashish, and hallucinations, International Journal of the Addictions, vol.6, issue.3, pp.553-560, 1971.
DOI : 10.3109/10826087109045568

L. Kamin, Punishment and aversive behavior, pp.279-296, 1969.

J. T. Kantrowitz and D. C. Javitt, N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation : the final common pathway on the road to schizophrenia ?, Brain Research Bulletin, vol.83, issue.3-4, pp.108-121, 2010.
DOI : 10.1016/j.brainresbull.2010.04.006

URL : http://europepmc.org/articles/pmc2941541?pdf=render

S. Kapur, Psychosis as a state of aberrant salience : a framework linking biology, phenomenology, and pharmacology in schizophrenia, Am J Psychiatry, vol.160, issue.1, pp.13-23, 2003.

S. Kapur, A. G. Phillips, and T. R. Insel, Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it ? Molecular Psychiatry, vol.17, pp.1174-1179, 2012.
DOI : 10.1038/mp.2012.105

URL : https://www.nature.com/articles/mp2012105.pdf

K. S. Kendler, A joint history of the nature of genetic variation and the nature of schizophrenia, Molecular Psychiatry, vol.20, issue.1, pp.77-83, 2015.

M. Keramati, A. Dezfouli, and P. Piray, Speed/accuracy trade-off between the habitual and the goal-directed processes, PLoS Computational Biology, vol.7, issue.5, 2011.
DOI : 10.1371/journal.pcbi.1002055

URL : https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1002055&type=printable

M. Keramati, P. Smittenaar, R. J. Dolan, and P. Dayan, Adaptive integration of habits into depth-limited planning defines a habitual-goal-directed spectrum, Proceedings of the National Academy of Sciences of the United States of America, 2016.

M. S. Keshavan, S. Kulkarni, T. Bhojraj, A. Francis, V. Diwadkar et al., Premorbid cognitive deficits in young relatives of schizophrenia patients, Frontiers in Human Neuroscience, vol.3, 2010.

A. S. Kesselheim, T. J. Hwang, and J. M. Franklin, Two decades of new drug development for central nervous system disorders, Nature Reviews. Drug Discovery, vol.14, issue.12, pp.815-816, 2015.

E. Kim, O. D. Howes, F. E. Turkheimer, B. Kim, J. M. Jeong et al.,

J. S. Kwon, The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory : A dual [(11)C]raclopride and [(18)F]FDG imaging study with aripiprazole, Psychopharmacology, vol.227, issue.2, pp.221-229, 2013.


H. Kim, S. Shimojo, and J. P. Doherty, Overlapping responses for the expectation of juice and money rewards in human ventromedial prefrontal cortex, Cerebral Cortex, vol.21, issue.4, pp.769-776, 2011.

P. Kirsch, A. Schienle, R. Stark, G. Sammer, C. Blecker et al., Anticipation of reward in a nonaversive differential conditioning paradigm and the brain reward system : an event-related fMRI study, NeuroImage, vol.20, issue.2, pp.381-382, 2003.

N. Y. Kirson, P. J. Weiden, S. Yermakov, W. Huang, T. Samuelson et al., Efficacy and effectiveness of depot versus oral antipsychotics in schizophrenia : synthesizing results across different research designs, The Journal of Clinical Psychiatry, vol.74, issue.6, pp.568-575, 2013.

K. T. Kishida, I. Saez, T. Lohrenz, M. R. Witcher, A. W. Laxton et al.,

P. R. Montague, Subsecond dopamine fluctuations in human striatum encode superposed error signals about actual and counterfactual reward, Proceedings of the National Academy of Sciences of the United States of America, vol.113, pp.200-205, 2016.

T. Kishimoto, M. Nitta, M. Borenstein, J. M. Kane, and C. U. Correll, Longacting injectable versus oral antipsychotics in schizophrenia : a systematic review and meta-analysis of mirror-image studies, The Journal of Clinical Psychiatry, vol.74, issue.10, pp.957-965, 2013.

T. Kishimoto, A. Robenzadeh, C. Leucht, S. Leucht, K. Watanabe et al.,

C. U. Correll, Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia : a meta-analysis of randomized trials, Schizophrenia Bulletin, vol.40, issue.1, pp.192-213, 2014.

L. Klei, S. J. Sanders, M. T. Murtha, V. Hus, J. K. Lowe et al.,

B. Devlin, Common genetic variants, acting additively, are a major source of risk for autism, Molecular Autism, vol.3, issue.1, 2012.

A. Knight, Systematic reviews of animal experiments demonstrate poor contributions toward human healthcare, Reviews on Recent Clinical Trials, vol.3, issue.2, pp.89-96, 2008.

B. Knutson, J. Burgdorf, and J. Panksepp, Ultrasonic vocalizations as indices of affective states in rats, Psychological Bulletin, vol.128, issue.6, pp.961-977, 2002.

S. Kobayashi, J. Lauwereyns, M. Koizumi, M. Sakagami, and O. Hikosaka, Influence of reward expectation on visuospatial processing in macaque lateral prefrontal cortex, Journal of Neurophysiology, vol.87, issue.3, pp.1488-1498, 2002.

E. Koechlin, An evolutionary computational theory of prefrontal executive function in decision-making, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, p.369, 1655.

I. Kola and J. Landis, Can the pharmaceutical industry reduce attrition rates ?, Nature Reviews. Drug Discovery, vol.3, issue.8, pp.711-715, 2004.

N. Koutsouleris, S. Borgwardt, E. M. Meisenzahl, R. Bottlender, H. Möller et al., Disease prediction in the at-risk mental state for psychosis using neuroanatomical biomarkers : results from the FePsy study, Schizophrenia Bulletin, vol.38, issue.6, pp.1234-1246, 2012.

N. Koutsouleris, C. Davatzikos, R. Bottlender, K. Patschurek-kliche, J. Scheuerecker et al., Early recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classification, Schizophrenia Bulletin, vol.38, issue.6, pp.1200-1215, 2012.

N. Koutsouleris, E. M. Meisenzahl, C. Davatzikos, R. Bottlender, T. Frodl et al., Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition, Archives of General Psychiatry, vol.66, issue.7, pp.700-712, 2009.

I. Koychev, K. Mcmullen, J. Lees, R. Dadhiwala, L. Grayson et al.,

E. Barkus, A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy : a three-center double-blind placebocontrolled study, European Neuropsychopharmacology, vol.22, issue.7, pp.469-481, 2012.

G. Kreiman, Single unit approaches to human vision and memory, Current Opinion in Neurobiology, vol.17, issue.4, pp.471-475, 2007.

G. Kreiman, I. Fried, and C. Koch, Single-neuron correlates of subjective vision in the human medial temporal lobe, Proceedings of the National Academy of Sciences of the United States of America, vol.99, pp.8378-8383, 2002.

E. E. Krieckhaus and G. Wolf, Acquisition of sodium by rats : interaction of innate mechanisms and latent learning, Journal of Comparative and Physiological Psychology, vol.65, issue.2, pp.197-201, 1968.

K. Hill, S. Buchholz, A. Amsbaugh, H. Reilly, J. L. Rubin et al., Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment, Research, vol.166, issue.1-3, pp.310-315, 2015.

R. A. Kronmal, K. C. Cain, Z. Ye, and G. S. Omenn, Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data, Archives of Internal Medicine, vol.153, issue.9, pp.1065-1073, 1993.

J. H. Krystal, A. Anand, and B. Moghaddam, Effects of NMDA receptor antagonists : implications for the pathophysiology of schizophrenia, Archives of General Psychiatry, vol.59, issue.7, pp.663-664, 2002.

J. H. Krystal, L. P. Karper, J. P. Seibyl, G. K. Freeman, R. Delaney et al., Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses, Archives of General Psychiatry, vol.51, issue.3, pp.199-214, 1994.

J. H. Krystal, E. B. Perry, R. Gueorguieva, A. Belger, S. H. Madonick et al.,

D. C. D'souza, Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine : implications for glutamatergic and dopaminergic model psychoses and cognitive function, Arch Gen Psychiatry, vol.62, issue.9, pp.985-994, 2005.

P. A. Kyzas, D. Denaxa-kyza, and J. P. Ioannidis, Almost all articles on cancer prognostic markers report statistically significant results, European Journal of Cancer, vol.43, issue.17, pp.2559-2579, 2007.
DOI : 10.1016/j.ejca.2007.08.030

H. Laborit, P. Huguenard, and R. Alluaume, Un nouveau stabilisateur végétatif (le 4560 RP), La Presse Medicale, vol.60, issue.10, pp.206-208, 1952.

M. Lafeuille, J. Dean, V. Carter, M. S. Duh, J. Fastenau et al., Systematic review of long-acting injectables versus oral atypical antipsychotics on hospitalization in schizophrenia, Current Medical Research and Opinion, vol.30, issue.8, pp.1643-1655, 2014.

A. C. Lahti, M. A. Weiler, B. A. Michaelidis, A. Parwani, and C. A. Tamminga, Effects of ketamine in normal and schizophrenic volunteers, Neuropsychopharmacology, vol.25, issue.4, pp.243-246, 2001.

&. Langreth and . Waldholz, New era of personalized medicine : targeting drugs for each unique genetic profile, The Oncologist, vol.4, issue.5, pp.426-427, 1999.

C. H. Large, Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs, Journal of Psychopharmacology, vol.21, issue.3, pp.283-301, 2007.

T. Larsen and J. P. Doherty, Uncovering the spatio-temporal dynamics of value-based decision-making in the human brain : a combined fMRI-EEG study, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, p.369, 1655.

B. Lau and P. W. Glimcher, Action and outcome encoding in the primate caudate nucleus, The Journal of Neuroscience, vol.27, issue.52, pp.14502-14514, 2007.

J. F. Leckman, Tourette's syndrome, Lancet, vol.360, issue.9345, pp.1577-1586, 2002.

D. Lee, Decision making : from neuroscience to psychiatry, Neuron, vol.78, issue.2, pp.233-248, 2013.
DOI : 10.1016/j.neuron.2013.04.008

URL : https://doi.org/10.1016/j.neuron.2013.04.008

D. Lee, H. Seo, and M. W. Jung, Neural basis of reinforcement learning and decision making, Annual Review of Neuroscience, vol.35, pp.287-308, 2012.
DOI : 10.1146/annurev-neuro-062111-150512

URL : http://europepmc.org/articles/pmc3490621?pdf=render

S. W. Lee, S. Shimojo, and J. P. Doherty, Neural computations underlying arbitration between model-based and model-free learning, Neuron, vol.81, issue.3, pp.687-699, 2014.
DOI : 10.1016/j.neuron.2013.11.028

URL : https://doi.org/10.1016/j.neuron.2013.11.028

T. Lencz and A. K. Malhotra, Targeting the schizophrenia genome : a fast track strategy from GWAS to clinic, Molecular Psychiatry, vol.20, issue.7, pp.820-826, 2015.
DOI : 10.1038/mp.2015.28

URL : https://www.nature.com/articles/mp201528.pdf

M. F. Lenzenweger, Thinking clearly about the endophenotype-intermediate phenotype-biomarker distinctions in developmental psychopathology research. Development and Psychopathology, vol.25, pp.1347-1357, 2013.
DOI : 10.1017/s0954579413000655

D. A. Lewis and P. Levitt, Schizophrenia as a disorder of neurodevelopment, Annual Review of Neuroscience, vol.25, pp.409-432, 2002.

J. Li and N. D. Daw, Signals in human striatum are appropriate for policy update rather than value prediction, The Journal of Neuroscience, vol.31, issue.14, pp.5504-5511, 2011.

P. Lichtenstein, B. H. Yip, C. Björk, Y. Pawitan, T. D. Cannon et al., Common genetic determinants of schizophrenia and bipolar disorder in Swedish families : a population-based study, Lancet, vol.373, issue.9659, pp.60072-60078, 2009.

J. A. Lieberman, T. S. Stroup, J. P. Mcevoy, M. S. Swartz, R. A. Rosenheck et al., Effectiveness of antipsychotic drugs in patients with chronic schizophrenia, The New England Journal of Medicine, vol.353, issue.12, pp.1209-1223, 2005.

B. K. Lipska, Using animal models to test a neurodevelopmental hypothesis of schizophrenia, Journal of Psychiatry and Neuroscience, vol.29, issue.4, pp.282-286, 2004.

B. K. Lipska and D. R. Weinberger, To model a psychiatric disorder in animals : schizophrenia as a reality test, Neuropsychopharmacology, vol.23, issue.3, pp.223-239, 2000.

, , pp.137-145

B. K. Lipska, G. E. Jaskiw, and D. R. Weinberger, Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage : a potential animal model of schizophrenia, Neuropsychopharmacology, vol.9, issue.1, pp.67-75, 1993.

B. K. Lipska, N. R. Swerdlow, M. A. Geyer, G. E. Jaskiw, D. L. Braff et al., Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine, Psychopharmacology, vol.122, issue.1, pp.35-43, 1995.

W. Liu, J. P. Roiser, L. Wang, Y. Zhu, J. Huang et al.,

R. C. Chan, Anhedonia is associated with blunted reward sensitivity in first-degree relatives of patients with major depression, Journal of Affective Disorders, vol.190, pp.640-648, 2016.

X. Liu, J. Hairston, M. Schrier, and J. Fan, Common and distinct networks underlying reward valence and processing stages : a meta-analysis of functional neuroimaging studies, Neuroscience and Biobehavioral Reviews, vol.35, issue.5, pp.1219-1236, 2011.

T. Lohrenz, K. Mccabe, C. F. Camerer, and P. R. Montague, Neural signature of fictive learning signals in a sequential investment task, Proceedings of the National Academy of Sciences of the United States of America, vol.104, pp.9493-9498, 2007.

G. Loomes and R. Sugden, Regret theory : An alternative theory of rational choice under uncertainty, The Economic Journal, vol.92, issue.368, pp.805-824, 1982.

C. Louis, C. Cohen, R. Depoortére, and G. Griebel, Antidepressant-like effects of the corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72 s schedule in the rat, Neuropsychopharmacology, issue.10, pp.2180-2187, 2006.

E. D. Luby, B. D. Cohen, G. Rosenbaum, J. S. Gottlieb, and R. Keller, Study of a new schizophrenomimetic drug ; sernyl, A.M.A. Archives of Neurology and Psychiatry, vol.81, issue.3, pp.363-369, 1959.

Y. Ma, Neuropsychological mechanism underlying antidepressant effect : a systematic meta-analysis, Molecular Psychiatry, vol.20, issue.3, pp.311-319, 2015.

M. R. Macleod, S. Michie, I. Roberts, U. Dirnagl, I. Chalmers et al., Biomedical research : increasing value, reducing waste, Lancet, vol.383, issue.9912, pp.62329-62335, 2014.

J. Macoveanu, P. M. Fisher, M. E. Haahr, V. G. Frokjaer, G. M. Knudsen et al., Effects of selective serotonin reuptake inhibition on neural activity related to risky decisions and monetary rewards in healthy males, NeuroImage, vol.99, pp.434-442, 2014.

J. Macoveanu, U. Knorr, A. Skimminge, M. G. Søndergaard, A. Jørgensen et al., Altered reward processing in the orbitofrontal cortex and hippocampus in healthy first-degree relatives of patients with depression, Psychological Medicine, vol.44, issue.6, pp.1183-1195, 2014.

T. V. Maia and M. J. Frank, From reinforcement learning models to psychiatric and neurological disorders, Nature Neuroscience, vol.14, issue.2, pp.154-162, 2011.

R. T. Malison, C. J. Mcdougle, C. H. Van-dyck, L. Scahill, R. M. Baldwin et al., Innis, R. B. (1995). [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder, Am J Psychiatry, vol.152, issue.9, pp.1359-1361

K. Matsumoto, W. Suzuki, and K. Tanaka, Neuronal correlates of goalbased motor selection in the prefrontal cortex, Science, vol.301, issue.5630, pp.229-232, 2003.

M. Matsumoto, K. Matsumoto, H. Abe, and K. Tanaka, Medial prefrontal cell activity signaling prediction errors of action values, Nature Neuroscience, vol.10, issue.5, pp.647-656, 2007.

C. Mccabe, Z. Mishor, P. J. Cowen, and C. J. Harmer, Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment, Biol Psychiatry, vol.67, issue.5, pp.439-445, 2010.

S. E. Mccarthy, J. Gillis, M. Kramer, J. Lihm, S. Yoon et al., De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability, Molecular Psychiatry, vol.19, issue.6, pp.652-658, 2014.

J. P. Mcevoy and O. Freudenreich, Animal and Translational Models for, Psychiatric Disorders, vol.1, pp.75-95, 2008.

P. R. Mchugh, Striving for coherence : psychiatry's efforts over classification, 2005.

, JAMA, vol.293, issue.20, pp.2526-2528

W. T. Mckinney and W. E. Bunney, Animal model of depression. I. Review of evidence : implications for research, Archives of General Psychiatry, vol.21, issue.2, pp.240-248, 1969.

A. Meyer-lindenberg, From maps to mechanisms through neuroimaging of schizophrenia, Nature, vol.468, issue.7321, pp.194-202, 2010.

M. Gazzaniga, G. M. , and R. Ivry, Cognitive Neuroscience. The Biology of the Mind, 2014.

K. A. Miczek, Animal and Translational Models for CNS Drug Discovery, vol.1, pp.97-116, 2008.

M. J. Millan, Animal and Translational Models for CNS Drug Discovery, vol.1, pp.1-58, 2008.

G. Miller, Psychiatry. Beyond DSM : seeking a brain-based classification of mental illness, Science, vol.327, issue.5972, p.1437, 2010.

M. J. Minzenberg, A. R. Laird, S. Thelen, C. S. Carter, and D. C. Glahn,

, Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia, Archives of General Psychiatry, vol.66, issue.8, pp.811-822

K. Minzer, O. Lee, J. J. Hong, and H. S. Singer, Increased prefrontal D2 protein in Tourette syndrome : a postmortem analysis of frontal cortex and striatum, J Neurol Sci, vol.219, issue.1-2, pp.55-61, 2004.

K. W. Miskowiak, H. L. Kjaerstad, I. Meluken, J. Z. Petersen, B. R. Maciel et al., The search for neuroimaging and cognitive endophenotypes : A critical systematic review of studies involving unaffected firstdegree relatives of individuals with bipolar disorder, Neuroscience and Biobehavioral Reviews, vol.73, pp.1-22, 2017.

R. E. Mistlberger, Circadian food-anticipatory activity : formal models and physiological mechanisms, Neuroscience and Biobehavioral Reviews, vol.18, issue.2, pp.171-195, 1994.

B. Moghaddam and J. H. Krystal, Capturing the angel in "angel dust" : twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans, Schizophr Bull, vol.38, issue.5, pp.942-949, 2012.

P. R. Montague, R. J. Dolan, K. J. Friston, and P. Dayan, Computational psychiatry, Trends Cogn Sci, vol.16, issue.1, pp.72-80, 2012.

J. W. Moore, V. C. Cambridge, H. Morgan, F. Giorlando, R. Adapa et al., Time, action and psychosis : Using subjective time to investigate the effects of ketamine on sense of agency, Neuropsychologia, vol.51, issue.2, pp.377-384, 2013.

C. J. Morgan, H. V. Curran, and I. S. Drugs, Ketamine use : a review, Addiction, vol.107, issue.1, pp.27-38, 2012.

H. L. Morgan, D. C. Turner, P. R. Corlett, A. R. Absalom, R. Adapa et al., Exploring the impact of ketamine on the experience of illusory body ownership, Biol Psychiatry, vol.69, issue.1, pp.35-41, 2011.

G. Morris, A. Nevet, D. Arkadir, E. Vaadia, and H. Bergman, Midbrain dopamine neurons encode decisions for future action, Nature Neuroscience, vol.9, issue.8, pp.1057-1063, 2006.

S. S. Moy and J. J. Nadler, Advances in behavioral genetics : mouse models of autism, Molecular Psychiatry, vol.13, issue.1, pp.4-26, 2008.

K. F. Muenzinger, Vicarious trial and error at a point of choice : I. A general survey of its relation to learning efficiency, The Pedagogical Seminary and Journal of Genetic Psychology, vol.53, issue.1, pp.75-86, 1938.

R. M. Murray, A. Paparelli, P. D. Morrison, A. Marconi, and M. Di-forti, What can we learn about schizophrenia from studying the human model, druginduced psychosis ?, American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, vol.162, issue.7, pp.661-670, 2013.

L. Naccache, I. El-karoui, M. Salti, M. Chammat, M. Maillet et al., , 2015.

T. Nagai, Y. Kitahara, D. Ibi, T. Nabeshima, A. Sawa et al., Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal polyI :C treatment, Behavioural Brain Research, vol.225, issue.1, pp.305-310, 2011.

N. A. Namhc, Report of the National Advisory Mental Health Council ?s Workgroup. National Collaborating Centre for Mental Health (UK). (2010). Depression : The Treatment and Management of Depression in Adults, 2010.

E. J. Nestler and S. E. Hyman, Animal models of neuropsychiatric disorders, Nature Neuroscience, vol.13, issue.10, pp.1161-1169, 2010.

D. M. Nielsen, G. J. Carey, and L. H. Gold, Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice, European Journal of Pharmacology, vol.499, issue.1-2, pp.135-146, 2004.

J. B. Nitschke, G. E. Dixon, I. Sarinopoulos, S. J. Short, J. D. Cohen et al., Altering expectancy dampens neural response to aversive taste in primary taste cortex, Nat Neurosci, vol.9, issue.3, pp.435-442, 2006.

Y. Niv and G. Schoenbaum, Dialogues on prediction errors, Trends in Cognitive Sciences, vol.12, issue.7, pp.265-272, 2008.

D. J. Nutt and A. C. Need, Where now for schizophrenia research ?, European Neuropsychopharmacology, vol.24, issue.8, pp.1181-1187, 2014.

J. Olds and P. Milner, Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain, Journal of Comparative and Physiological Psychology, vol.47, issue.6, pp.419-427, 1954.

D. H. Overstreet and G. Griebel, Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression, European Journal of Pharmacology, vol.497, issue.1, pp.49-53, 2004.

M. J. Owen, M. C. O'donovan, A. Thapar, and N. Craddock, Neurodevelopmental hypothesis of schizophrenia, The British Journal of Psychiatry, vol.198, issue.3, pp.173-175, 2011.

J. P. O'doherty, P. Dayan, K. Friston, H. Critchley, and R. J. Dolan, Temporal difference models and reward-related learning in the human brain, Neuron, vol.38, issue.2, pp.329-337, 2003.

J. P. O'doherty, R. Deichmann, H. D. Critchley, and R. J. Dolan, Neural responses during anticipation of a primary taste reward, Neuron, vol.33, issue.5, pp.815-826, 2002.

J. P. O'doherty, A. Hampton, and H. Kim, Model-based fMRI and its application to reward learning and decision making, Annals of the New York Academy of Sciences, vol.1104, pp.35-53, 2007.

J. P. O'doherty, S. W. Lee, and D. Mcnamee, The structure of reinforcementlearning mechanisms in the human brain, Current Opinion in Behavioral Sciences, vol.1, pp.94-100, 2015.

C. Padoa-schioppa and J. A. Assad, Neurons in the orbitofrontal cortex encode economic value, Nature, issue.7090, pp.223-226, 2006.

S. Palminteri, A. Clair, L. Mallet, and M. Pessiglione, Similar improvement of reward and punishment learning by serotonin reuptake inhibitors in obsessive-compulsive disorder, Biol Psychiatry, vol.72, issue.3, pp.244-250, 2012.

S. Palminteri, D. Justo, C. Jauffret, B. Pavlicek, A. Dauta et al.,

M. Pessiglione, Critical roles for anterior insula and dorsal striatum in punishment-based avoidance learning, Neuron, vol.76, issue.5, pp.998-1009, 2012.

S. Palminteri, M. Lebreton, Y. Worbe, D. Grabli, A. Hartmann et al., Pharmacological modulation of subliminal learning in Parkinson's and Tourette's syndromes, Proc Natl Acad Sci U S A, vol.106, issue.45, pp.19179-19184, 2009.

W. M. Pardridge, Crossing the blood-brain barrier : are we getting it right ? Drug Discovery Today, vol.6, pp.1-2, 2001.

J. Pearl, Heuristics : intelligent search strategies for computer problem solving, 1984.

P. Perel, I. Roberts, E. Sena, P. Wheble, C. Briscoe et al., Comparison of treatment effects between animal experiments and clinical trials : systematic review, British Medical Journal, vol.334, issue.7586, 2007.

M. L. Pergadia, A. Der-avakian, M. S. Souza, P. A. Madden, A. C. Heath et al., Association between nicotine withdrawal and reward responsiveness in humans and rats, JAMA Psychiatry, vol.71, issue.11, pp.1238-1245, 2014.

E. B. Perry, J. A. Cramer, H. Cho, I. L. Petrakis, L. P. Karper et al., Psychiatric safety of ketamine in psychopharmacology research, Psychopharmacology, vol.192, issue.2, pp.253-260, 2007.

M. Pessiglione, P. Petrovic, J. Daunizeau, S. Palminteri, R. J. Dolan et al., Subliminal instrumental conditioning demonstrated in the human brain, Neuron, vol.59, issue.4, pp.561-567, 2008.

M. Pessiglione, B. Seymour, G. Flandin, R. J. Dolan, &. D. et al., , 2006.

, Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans, Nature, issue.7106, pp.1042-1045

A. Petronis, I. I. Gottesman, T. J. Crow, L. E. Delisi, A. J. Klar et al., Psychiatric epigenetics : a new focus for the new century, Molecular Psychiatry, vol.5, issue.4, pp.342-346, 2000.

A. G. Phillips and A. M. Barr, Effects of chronic mild stress on motivation for sucrose : mixed messages, Psychopharmacology, vol.134, issue.4, pp.371-378, 1997.

B. S. Pickard, Schizophrenia biomarkers : translating the descriptive into the diagnostic, Journal of Psychopharmacology, vol.29, issue.2, pp.138-143, 2015.

D. A. Pizzagalli, A. L. Jahn, and J. P. Shea, Toward an objective characterization of an anhedonic phenotype : a signal-detection approach, Biological Psychiatry, vol.57, issue.4, pp.319-327, 2005.

M. V. Pletnikov, Y. Ayhan, O. Nikolskaia, Y. Xu, M. V. Ovanesov et al.,

C. A. Ross, Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia, Molecular Psychiatry, vol.13, issue.2, pp.173-86, 2008.

E. M. Poels, L. S. Kegeles, J. T. Kantrowitz, M. Slifstein, D. C. Javitt et al.,

R. R. Girgis, Imaging glutamate in schizophrenia : review of findings and implications for drug discovery, Molecular Psychiatry, vol.19, issue.1, pp.20-29, 2014.

E. Pomarol-clotet, G. D. Honey, G. K. Murray, P. R. Corlett, A. R. Absalom et al., Psychological effects of ketamine in healthy volunteers. Phenomenological study, The British Journal of Psychiatry, vol.189, pp.173-179, 2006.

R. D. Porsolt, G. Anton, N. Blavet, and M. Jalfre, Behavioural despair in rats : a new model sensitive to antidepressant treatments, European Journal of Pharmacology, vol.47, issue.4, pp.379-391, 1978.

S. H. Preskorn, CNS drug development. Part I : The early period of CNS drugs, Journal of Psychiatric Practice, vol.16, issue.5, pp.334-339, 2010.

J. Price, V. Cole, and G. M. Goodwin, Emotional side-effects of selective serotonin reuptake inhibitors : qualitative study, Br J Psychiatry, vol.195, issue.3, pp.211-217, 2009.

V. K. Rakyan, J. Preis, H. D. Morgan, and E. Whitelaw, The marks, mechanisms and memory of epigenetic states in mammals, The Biochemical Journal, vol.356, pp.1-10, 2001.

S. Ramboz, R. Oosting, D. A. Amara, H. F. Kung, P. Blier et al., Serotonin receptor 1A knockout : an animal model of anxietyrelated disorder, Proceedings of the National Academy of Sciences of the United States of America, vol.95, issue.24, pp.14476-14481, 1998.

P. Redgrave, M. Rodriguez, Y. Smith, M. C. Rodriguez-oroz, S. Lehericy et al., Goal-directed and habitual control in the basal ganglia : implications for Parkinson's disease, Nature Reviews. Neuroscience, vol.11, issue.11, pp.760-772, 2010.

D. Regoli, A. Boudon, and J. L. Fauchére, Receptors and antagonists for substance P and related peptides, Pharmacological Reviews, vol.46, issue.4, pp.551-599, 1994.
DOI : 10.1159/000138512

R. A. Rescorla and A. R. Wagner, Classical conditioning II : Current research and theory, Classical conditioning II : Current research and theory, vol.2, pp.64-99, 1972.

K. J. Ressler and H. S. Mayberg, Targeting abnormal neural circuits in mood and anxiety disorders : from the laboratory to the clinic, Nature Neuroscience, vol.10, issue.9, pp.1116-1124, 2007.

S. H. Richter, J. P. Garner, and H. Würbel, Environmental standardization : cure or cause of poor reproducibility in animal experiments ?, Nature Methods, vol.6, issue.4, pp.257-261, 2009.

S. H. Richter, J. P. Garner, C. Auer, J. Kunert, and H. Würbel, Systematic variation improves reproducibility of animal experiments, Nature Methods, vol.7, issue.3, pp.167-168, 2010.
DOI : 10.1038/nmeth0310-167

T. W. Robbins, Homology in behavioural pharmacology : an approach to animal models of human cognition, Behavioural Pharmacology, vol.9, issue.7, pp.509-519, 1998.

T. W. Robbins, C. M. Gillan, D. G. Smith, S. Wit, . De et al., , 2012.

, Neurocognitive endophenotypes of impulsivity and compulsivity : towards dimensional psychiatry, Trends in Cognitive Sciences, vol.16, issue.1, pp.81-91

M. Rosenblatt, The Large Pharmaceutical Company Perspective, The New England Journal of Medicine, vol.376, issue.1, pp.52-60, 2017.
DOI : 10.1056/nejmra1510069

S. L. Rossell, The Neuroscience of Hallucinations, pp.137-152, 2012.

A. J. Rush, M. H. Trivedi, S. R. Wisniewski, A. A. Nierenberg, J. W. Stewart et al., Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps : a STAR*D report, The American Journal of Psychiatry, vol.163, issue.11, pp.1905-1917, 2006.

H. M. Salzer and M. L. Lurie, Anxiety and depressive states treated with isonicotinyl hydrazide (isoniazid), A.M.A. Archives of Neurology and Psychiatry, vol.70, issue.3, pp.317-324, 1953.

K. Samejima, Y. Ueda, K. Doya, and M. Kimura, Representation of action-specific reward values in the striatum, Science, issue.5752, pp.1337-1340, 2005.

F. Sams-dodd, B. K. Lipska, and D. R. Weinberger, Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood, Psychopharmacology, vol.132, issue.3, pp.303-310, 1997.

L. Santarelli, M. Saxe, C. Gross, A. Surget, F. Battaglia et al., Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants, Science, vol.301, issue.5634, pp.805-809, 2003.

R. Santos, O. Ursu, A. Gaulton, A. P. Bento, R. S. Donadi et al.,

J. P. Overington, A comprehensive map of molecular drug targets, Nature Reviews. Drug Discovery, vol.16, issue.1, pp.19-34, 2017.

L. Scahill, D. G. Sukhodolsky, S. K. Williams, and J. F. Leckman, Public health significance of tic disorders in children and adolescents, Advances in Neurology, vol.96, pp.240-248, 2005.

E. Scarr, M. J. Millan, S. Bahn, A. Bertolino, C. W. Turck et al., Biomarkers for Psychiatry : The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank, The International Journal of Neuropsychopharmacology, vol.18, issue.10, 2015.

R. W. Scherer, P. Langenberg, and E. V. Elm, Full publication of results initially presented in abstracts. The Cochrane Database of Systematic Reviews, 2007.

A. Schmidt, R. Bachmann, M. Kometer, P. A. Csomor, K. E. Stephan et al., Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments, Neuropsychopharmacology, vol.37, issue.4, pp.865-875, 2012.
DOI : 10.1038/npp.2011.261

URL : https://www.nature.com/articles/npp2011261.pdf

T. Schönberg, N. D. Daw, D. Joel, and J. P. Doherty, Reinforcement learning signals in the human striatum distinguish learners from nonlearners during reward-based decision making, The Journal of Neuroscience, vol.27, issue.47, pp.12860-12867, 2007.

W. Schultz, Responses of midbrain dopamine neurons to behavioral trigger stimuli in the monkey, Journal of Neurophysiology, vol.56, issue.5, pp.1439-1461, 1986.

W. Schultz, Getting formal with dopamine and reward, Neuron, vol.36, issue.2, pp.241-263, 2002.
DOI : 10.1016/s0896-6273(02)00967-4

URL : https://doi.org/10.1016/s0896-6273(02)00967-4

W. Schultz, Updating dopamine reward signals. Current Opinion in Neurobiology, vol.23, pp.229-238, 2013.
DOI : 10.1016/j.conb.2012.11.012

URL : https://doi.org/10.1016/j.conb.2012.11.012

W. Schultz, P. Dayan, and P. R. Montague, A neural substrate of prediction and reward, Science, vol.275, issue.5306, pp.1593-1599, 1997.
DOI : 10.1126/science.275.5306.1593

URL : http://www.cs.utexas.edu/~dana/Reward.pdf

E. Schwarz, R. Izmailov, M. Spain, A. Barnes, J. P. Mapes et al.,

S. Bahn, Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia, Biomarker Insights, vol.5, pp.39-47, 2010.

B. Segura and A. P. Strafella, Functional imaging of dopaminergic neurotransmission in Tourette syndrome, International Review of Neurobiology, vol.112, pp.73-93, 2013.

I. J. Selikoff and E. H. Robitzek, Tuberculosis chemotherapy with hydrazine derivatives of isonicotinic acid, Diseases of the Chest, vol.21, issue.4, pp.385-438, 1952.

B. Seymour, T. Singer, and R. Dolan, The neurobiology of punishment, Nature Reviews. Neuroscience, vol.8, issue.4, pp.300-311, 2007.

M. Shahbazian, J. Young, L. Yuva-paylor, C. Spencer, B. Antalffy et al., Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3, Neuron, vol.35, issue.2, pp.243-254, 2002.

D. A. Shapiro, S. Renock, E. Arrington, L. A. Chiodo, L. Liu et al., Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology, Neuropsychopharmacology, vol.28, issue.8, pp.1400-1411, 2003.

R. A. Shih, P. L. Belmonte, and P. P. Zandi, A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders, International Review of Psychiatry, vol.16, issue.4, pp.260-283, 2004.

H. S. Singer, Tourette's syndrome : from behaviour to biology, Lancet Neurol, vol.4, issue.3, pp.149-159, 2005.

Z. Sjoerds, S. Wit, . De, W. Brink, . Van-den et al., Behavioral and neuroimaging evidence for overreliance on habit learning in alcohol-dependent patients, Translational Psychiatry, vol.3, 2013.

B. F. Skinner, Behavior of Organisms, 2006.

D. J. Slamon, G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich et al., Human breast cancer : correlation of relapse and survival with amplification of the HER-2/neu oncogene, Science, vol.235, issue.4785, pp.177-182, 1987.

I. Smith, M. Procter, R. D. Gelber, S. Guillaume, A. Feyereislova et al., 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer : a randomised controlled trial, Lancet, vol.369, issue.9555, pp.29-36, 2007.

R. P. Snaith, M. Hamilton, S. Morley, A. Humayan, D. Hargreaves et al., A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale, The British Journal of Psychiatry, vol.167, issue.1, pp.99-103, 1995.

T. Sommer, J. Peters, J. Gläscher, and C. Büchel, Structure-function relationships in the processing of regret in the orbitofrontal cortex, Brain Structure and Function, vol.213, issue.6, pp.535-551, 2009.

M. J. Spilka, A. E. Arnold, and V. M. Goghari, Functional activation abnormalities during facial emotion perception in schizophrenia patients and nonpsychotic relatives, Schizophrenia Research, vol.168, issue.1-2, pp.330-337, 2015.

S. M. Stahl, Stahl's essential psychopharmacology : neuroscientific basis and practical applications, 2013.

H. Steeds, R. L. Carhart-harris, and J. M. Stone, Drug models of schizophrenia, Therapeutic Advances in Psychopharmacology, vol.5, issue.1, pp.43-58, 2015.

K. E. Stephan and C. Mathys, Computational approaches to psychiatry, Current Opinion in Neurobiology, vol.25, pp.85-92, 2014.

L. Steru, R. Chermat, B. Thierry, and P. Simon, The tail suspension test : a new method for screening antidepressants in mice, Psychopharmacology, vol.85, issue.3, pp.367-370, 1985.

I. P. Stolerman, M. Stoy, F. Schlagenhauf, P. Sterzer, F. Bermpohl et al., Encyclopedia of Psychopharmacology, 2015.

A. Ströhle, Hyporeactivity of ventral striatum towards incentive stimuli in unmedicated depressed patients normalizes after treatment with escitalopram, Journal of Psychopharmacology, vol.26, issue.5, pp.677-688, 2012.

P. F. Sullivan, M. J. Daly, and M. Donovan, Genetic architectures of psychiatric disorders : the emerging picture and its implications, Nature Reviews. Genetics, vol.13, issue.8, pp.537-551, 2012.

A. Surget, A. Tanti, E. D. Leonardo, A. Laugeray, Q. Rainer et al.,

C. Belzung, Antidepressants recruit new neurons to improve stress response regulation, Molecular Psychiatry, vol.16, issue.12, pp.1177-1188, 2011.

R. S. Sutton and A. G. Barto, Reinforcement Learning : An Introduction, 1998.

M. Suzuki, Role of N-methyl-D-aspartate receptor antagonists in postoperative pain management, Current Opinion in Anaesthesiology, vol.22, issue.5, pp.618-622, 2009.

C. Teufel and P. C. Fletcher, The promises and pitfalls of applying computational models to neurological and psychiatric disorders, Brain : A Journal of Neurology, vol.139, pp.2600-2608, 2016.

D. W. Thomas, J. Burns, J. Audette, A. Carroll, C. Dow-hygelund et al., Biotechnology Innovation Organization (BIO), 2006.

E. L. Thorndike, Animal Intelligence : Experimental Studies, 1911.

E. L. Thorndike, A theory of the action of the after-effects of a connection upon it, Psychological Review, vol.40, issue.5, p.434, 1933.

M. J. Tobia, R. Guo, U. Schwarze, W. Boehmer, J. Gläscher et al.,

T. Sommer, Neural systems for choice and valuation with counterfactual learning signals, NeuroImage, vol.89, pp.57-69, 2014.

P. N. Tobler, C. D. Fiorillo, and W. Schultz, Adaptive coding of reward value by dopamine neurons, Science, vol.307, issue.5715, pp.1642-1645, 2005.

E. C. Tolman and C. H. Honzik, Introduction and removal of reward, and maze performance in rats, 1930.

L. Tremblay and W. Schultz, Relative reward preference in primate orbitofrontal cortex, Nature, vol.398, issue.6729, pp.704-708, 1999.

L. Tremblay, Y. Worbe, S. Thobois, V. Sgambato-faure, and J. Féger, , 2015.

, Selective dysfunction of basal ganglia subterritories : From movement to behavioral disorders, Movement Disorders, vol.30, issue.9, pp.1155-1170

R. Turner, Uses, misuses, new uses and fundamental limitations of magnetic resonance imaging in cognitive science, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, p.371, 1705.

L. Valzelli, The "isolation syndrome" in mice, Psychopharmacologia, vol.31, issue.4, pp.305-320, 1973.

N. Van-hoeck, P. D. Watson, and A. K. Barbey, Cognitive neuroscience of human counterfactual reasoning, Frontiers in Human Neuroscience, vol.9, p.420, 2015.

M. H. Van-regenmortel, Reductionism and complexity in molecular biology. Scientists now have the tools to unravel biological and overcome the limitations of reductionism, EMBO Reports, vol.5, issue.11, pp.1016-1020, 2004.

O. J. Veatch, J. Veenstra-vanderweele, M. Potter, M. A. Pericak-vance, and J. L. Haines, Genetically meaningful phenotypic subgroups in autism spectrum disorders, Genes, Brain, and Behavior, vol.13, issue.3, pp.276-285, 2014.

F. Vinckier, R. Gaillard, S. Palminteri, L. Rigoux, A. Salvador et al., Confidence and psychosis : a neuro-computational account of contingency learning disruption by NMDA blockade, Mol Psychiatry, 2016.

P. A. Vöhringer and S. N. Ghaemi, Solving the antidepressant efficacy question : effect sizes in major depressive disorder, Clinical Therapeutics, vol.33, issue.12, pp.49-61, 2011.

P. Waelti, A. Dickinson, and W. Schultz, Dopamine responses comply with basic assumptions of formal learning theory, Nature, issue.6842, pp.43-48, 2001.

G. G. Wallis, J. F. Mcharg, and O. C. Scott, Acute psychosis caused by dextro-amphetamine, British Medical Journal, vol.2, issue.4641, p.1394, 1949.

J. D. Wallis, Cross-species studies of orbitofrontal cortex and value-based decision-making, Nature Neuroscience, vol.15, issue.1, pp.13-19, 2012.

J. A. Waltz, M. J. Frank, B. M. Robinson, and J. M. Gold, Selective reinforcement learning deficits in schizophrenia support predictions from computational models of striatal-cortical dysfunction, Biological Psychiatry, vol.62, issue.7, pp.756-764, 2007.

K. J. Wardenaar and P. D. Jonge, Diagnostic heterogeneity in psychiatry : towards an empirical solution, BMC Medicine, vol.11, 0201.

F. Waters, The Neuroscience of Hallucinations, pp.185-199, 2012.

C. J. Watkins and P. Dayan, Q-learning, Machine Learning, vol.8, pp.279-292, 1992.

C. A. Webb, D. G. Dillon, P. Pechtel, F. K. Goer, L. Murray et al.,

D. A. Pizzagalli, Neural Correlates of Three Promising Endophenotypes of Depression : Evidence from the EMBARC Study, Neuropsychopharmacology, vol.41, issue.2, pp.454-463, 2016.

M. C. Wichers, D. Q. Barge-schaapveld, N. A. Nicolson, F. Peeters, M. Vries et al., Reduced stress-sensitivity or increased reward experience : the psychological mechanism of response to antidepressant medication, Neuropsychopharmacology, vol.34, issue.4, pp.923-931, 2009.

T. V. Wiecki, J. Poland, and M. J. Frank, Model-based cognitive neuroscience approaches to computational psychiatry clustering and classification, Clinical Psychological Science, vol.3, issue.3, pp.378-399, 2015.

P. Willner, The validity of animal models of depression, Psychopharmacology, vol.83, issue.1, pp.1-16, 1984.

P. Willner, Validation criteria for animal models of human mental disorders : learned helplessness as a paradigm case, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.10, issue.6, pp.677-690, 1986.

P. Willner, Validity, reliability and utility of the chronic mild stress model of depression : a 10-year review and evaluation, Psychopharmacology, vol.134, issue.4, pp.319-329, 1997.

P. Willner, Encyclopedia of Psychopharmacology, Encyclopedia of Psychopharmacology, pp.115-121, 2015.

P. Willner and C. Belzung, Treatment-resistant depression : are animal models of depression fit for purpose ?, Psychopharmacology, vol.232, issue.19, pp.3473-3495, 2015.

P. Willner, F. Borsini, and R. A. Mcarthur, Animal and Translational Models for, Psychiatric Disorders, vol.1, pp.359-375, 2008.

P. Willner, A. Towell, D. Sampson, S. Sophokleous, and R. Muscat, Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant, Psychopharmacology, vol.93, issue.3, pp.358-364, 1987.

S. Wit, . De, P. Watson, H. A. Harsay, M. X. Cohen et al., Corticostriatal connectivity underlies individual differences in the balance between habitual and goal-directed action control, The Journal of Neuroscience, vol.32, issue.35, pp.12066-12075, 2012.

D. F. Wong, J. R. Brasi?, H. S. Singer, D. J. Schretlen, H. Kuwabara et al.,

A. A. Grace, Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome : clues from an in vivo neurochemistry study with PET, Neuropsychopharmacology, vol.33, issue.6, pp.1239-1251, 2008.

S. K. Wood, K. V. Mcfadden, D. Grigoriadis, S. Bhatnagar, and R. J. Valentino, Depressive and cardiovascular disease comorbidity in a rat model of social stress : a putative role for corticotropin-releasing factor, Psychopharmacology, vol.222, issue.2, pp.325-336, 2012.

M. Xu, A. Kobets, J. Du, J. Lennington, L. Li et al., Targeted ablation of cholinergic interneurons in the dorsolateral striatum produces behavioral manifestations of Tourette syndrome, Proceedings of the National Academy of Sciences of the United States of America, vol.112, issue.3, pp.893-898, 2015.


H. H. Yin and B. J. Knowlton, The role of the basal ganglia in habit formation, Nature Reviews. Neuroscience, vol.7, issue.6, pp.464-476, 2006.

D. Y. Yoon, C. D. Gause, J. F. Leckman, and H. S. Singer, Frontal dopaminergic abnormality in Tourette syndrome : a postmortem analysis, J Neurol Sci, vol.255, issue.1-2, pp.50-56, 2007.

C. A. Zarate, J. B. Singh, P. J. Carlson, N. E. Brutsche, R. Ameli et al., A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression, Arch Gen Psychiatry, vol.63, issue.8, pp.856-864, 2006.

M. Zeelenberg and R. Pieters, A theory of regret regulation 1.0, Journal of Consumer Psychology, vol.17, issue.1, pp.3-18, 2007.